Are you a biotech company developing innovative therapies, diagnostics, or digital tools in Alzheimer’s disease or neurodegeneration? CTAD25 invites you to take part in a unique visibility and networking opportunity designed to connect emerging biotechs with key clinical trial leaders, researchers, and investors.
Biotech Showcase Sessions – Flash Presentations During Coffee Breaks
As part of a new initiative at CTAD 2025, we are hosting dedicated Biotech Showcase Sessions — dynamic flash presentation slots where selected biotech companies will:
- Present their work in 3-minute / 3-slide lightning talks
- Engage in 2 minutes of live Q&A with moderators and attendees
- Gain expert feedback and investor attention
- Build high-value connections with leaders in AD clinical trials
These sessions will take place in a dedicated area during coffee breaks to ensure high visibility and engagement.
Why Participate?
- Elevate your company’s profile on an international stage
- Share your innovation with top experts in Alzheimer’s and neurodegeneration
- Get real-time feedback from clinical and industry leaders
- Connect with potential partners, collaborators, and investors
How to Apply
To be considered for a Biotech Showcase Session at CTAD25, please send the following information to ctad@ant-congres.com — or indicate your interest during abstract submission or event registration:
- Company therapeutic area
- Company & pipeline description (max 200 words)
- Innovation/product/device to be presented
- Presenter’s name, title, and email
Submissions will be reviewed by our organizing committee. Selected companies will receive confirmation and additional instructions.
ctad@ant-congres.com